Cargando…
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m(2) for definitive radiochemotherapy of locally advanced head-and-neck cancers
BACKGROUND: To compare definitive radiochemotherapy with weekly administration of 30–40 mg/m(2) of cisplatin to 100 mg/m(2) of cisplatin on days 1, 22 and 43 for outcomes and toxicity in patients with squamous cell carcinoma of the head-and-neck. METHODS: Seventy-five patients receiving radiochemoth...
Autores principales: | Rades, Dirk, Seidl, Daniel, Janssen, Stefan, Bajrovic, Amira, Karner, Katarina, Strojan, Primoz, Schild, Steven E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938984/ https://www.ncbi.nlm.nih.gov/pubmed/27391309 http://dx.doi.org/10.1186/s12885-016-2478-8 |
Ejemplares similares
-
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
por: Wiegand, Susanne, et al.
Publicado: (2023) -
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin
por: Kornek, G V, et al.
Publicado: (2000) -
Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer
por: Wolff, Hendrik Andreas, et al.
Publicado: (2008) -
First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m(2) Cisplatin for Locally Advanced Head and Neck Cancer
por: Zwaan, Inga, et al.
Publicado: (2023) -
A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases
por: Rades, Dirk, et al.
Publicado: (2017)